Lombard Odier Asset Management (Usa) Corp Accelerate Diagnostics, Inc Transaction History

Lombard Odier Asset Management (Usa) Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$11.76 - $22.15 $764,094 - $1.44 Million	-64,974 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.42 - $21.94 $781,770 - $1.65 Million	-75,026 Reduced 53.59%	64,974 $747,000
Q2 2018 Aug 14, 2018	BUY	$19.02 - $24.95 $760,800 - $998,000	40,000 Added 40.0%	140,000 $3.12 Million
Q1 2018 May 15, 2018	SELL	$22.55 - $29.9 $678,619 - $899,810	-30,094 Reduced 23.13%	100,000 $2.29 Million
Q4 2017 Feb 13, 2018	BUY	$18.0 - $30.0 $1.89 Million - $3.15 Million	105,094 Added 420.38%	130,094 $3.41 Million
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $527,500 - $628,750	25,000	25,000 $561,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $118M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.